124 related articles for article (PubMed ID: 10354660)
1. Pimozide augmentation in a patient with drug-resistant psychosis previously treated with olanzapine.
Takhar J
J Psychiatry Neurosci; 1999 May; 24(3):248-9. PubMed ID: 10354660
[No Abstract] [Full Text] [Related]
2. Management of treatment-resistant schizophrenia with olanzapine.
Thomas SG; Labbate LA
Can J Psychiatry; 1998 Mar; 43(2):195-6. PubMed ID: 9533977
[No Abstract] [Full Text] [Related]
3. The effectiveness of combining lithium with olanzapine in the treatment of resistant schizophrenia.
Martín JC; Palenciano G; Pérez R
J Clin Psychiatry; 2000 Dec; 61(12):948. PubMed ID: 11206602
[No Abstract] [Full Text] [Related]
4. Olanzapine.
Baldacchino AM; Stubbs JH; Mountjoy CQ
Hosp Med; 1998 Sep; 59(9):737. PubMed ID: 9829087
[No Abstract] [Full Text] [Related]
5. Olanzapine augmentation of clozapine.
Gupta S; Sonnenberg SJ; Frank B
Ann Clin Psychiatry; 1998 Sep; 10(3):113-5. PubMed ID: 9781474
[TBL] [Abstract][Full Text] [Related]
6. Fluoxetine augmentation with olanzapine for treatment of chronic resistant depression in an elderly patient: a case report.
Detweiler MB; Trinkle DB
J Clin Psychiatry; 2003 Jul; 64(7):851-2. PubMed ID: 12934994
[No Abstract] [Full Text] [Related]
7. [Zyprexa (olanzapine)--new possibilities in the treatment of schizophrenia].
Litvintsev SV; Reznik AM; Arbuzov AL; Kutushev OT; Shcherbakov DV
Voen Med Zh; 2002 Sep; 323(9):46-50. PubMed ID: 12449756
[No Abstract] [Full Text] [Related]
8. Clozapine to olanzapine.
Millson RC; Delva NJ
Am J Psychiatry; 1999 Jul; 156(7):1121. PubMed ID: 10401476
[No Abstract] [Full Text] [Related]
9. High-dose olanzapine for treatment-refractory schizophrenia.
Sheitman BB; Lindgren JC; Early J; Sved M
Am J Psychiatry; 1997 Nov; 154(11):1626. PubMed ID: 9356581
[No Abstract] [Full Text] [Related]
10. Olanzapine for violent schizophrenia and Klinefelter syndrome.
Dervaux A; Artiges E
Am J Psychiatry; 2002 Mar; 159(3):493-4. PubMed ID: 11870023
[No Abstract] [Full Text] [Related]
11. Review of recent clinical studies with olanzapine.
Tollefson GD; Kuntz AJ
Br J Psychiatry Suppl; 1999; (37):30-5. PubMed ID: 10211139
[TBL] [Abstract][Full Text] [Related]
12. Olanzapine-induced agranulocytosis.
Naumann R; Felber W; Heilemann H; Reuster T
Lancet; 1999 Aug; 354(9178):566-7. PubMed ID: 10470705
[TBL] [Abstract][Full Text] [Related]
13. Olanzapine and negative and positive symptoms.
Rifkin A
Am J Psychiatry; 2001 May; 158(5):825. PubMed ID: 11329430
[No Abstract] [Full Text] [Related]
14. Treatment of cervical dystonia by olanzapine.
Kuniyoshi M; Ohyama S; Otsuka M; Nishi S; Inanaga K; Mori N
Hum Psychopharmacol; 2003 Jun; 18(4):311-2. PubMed ID: 12766936
[No Abstract] [Full Text] [Related]
15. Reduction of tardive dystonia with olanzapine.
Jaffe ME; Simpson GM
Am J Psychiatry; 1999 Dec; 156(12):2016. PubMed ID: 10588425
[No Abstract] [Full Text] [Related]
16. Olanzapine.
Hale AS
Br J Hosp Med; 1997 Nov 5-18; 58(9):442-5. PubMed ID: 9619205
[TBL] [Abstract][Full Text] [Related]
17. Olanzapine on trial.
Mattes JA
Am J Psychiatry; 1998 Jan; 155(1):153; author reply 153-5. PubMed ID: 9433359
[No Abstract] [Full Text] [Related]
18. [Olanzapine--a new atypical neuroleptic. A chance for advancement in the therapy of schizophrenia].
Nervenarzt; 1997 Jul; 68(7 Suppl Olanzapin):1-8. PubMed ID: 9431360
[No Abstract] [Full Text] [Related]
19. High-dose olanzapine therapy in schizophrenia.
Alao AO; Armenta WA; Yolles JC
Ann Pharmacother; 1999 Nov; 33(11):1228. PubMed ID: 10573326
[No Abstract] [Full Text] [Related]
20. Olanzapine, sertindole and schizophrenia.
Drug Ther Bull; 1997 Nov; 35(11):81-3. PubMed ID: 9464002
[No Abstract] [Full Text] [Related]
[Next] [New Search]
